Please login to the form below
Blopress
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Blopress was produced by Takeda.
Takeda CEO admits to Blopress mis-marketing
Takeda CEO admits to Blopress mis-marketing. Campaign used graph indicating drug was superior to Pfizer’ s Norvasc. ... Blopress - also sold as Atacand - was a big seller for Takeda for many years, with sales approaching $2bn before it lost patent
Takeda rides out Actos decline as fiscal 2012 sales rise
steep decline for antihypertensive Blopress (candesartan), also on generic competition, which ended the year down 22 per cent to 169bn yen. ... The drug's US launch is due in the summer. Azilva also contributed to Takeda's domestic sales growth on the
Acquisitions soften Actos blow in Takeda's first-half results
As expected, Actos (pioglitazone) saw its sales slump 46 per cent to 92bn yen, while there were also significant declines for other drugs exposed to generic competition, notably antihypertensive Blopress (candesartan)
Takeda set for US sales slump as generic Actos arrives
Added to that, Takeda is also facing declining sales of another of its top products as a result of generic competition, such as antihypertensive Blopress (candesartan cilexetil) which had first-quarter
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Medical Writer, e-learning/ training, London
-
Excellent Salary
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Senior Medical Writer
-
Great salary and bebefits
-
Scientific Director
-
Great salary and bebefits
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
Four Health Media
Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal...
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
